-
Researchers Using Models To Understand COVID-19, Other News
Bio-IT World | Researchers are continuing to analyze COVID-19 through several models. A new mouse model is being developed in China to test and confirm the efficacy of a potential vaccine, while a researcher in the US is using computer models to understand the structure of the virus.
Aug 7, 2020
-
Time to Innovate for Faster, Smarter Discovery and Clinical Development Cycles
Bio-IT World Contributed Commentary | We’ve learned so much living through these unprecedented times. One lesson is the need to mobilize quickly, provide effective testing and contact tracing, and accelerate the development of therapies and vaccines to protect the global community. That can only be done through the power of data: the defining currency in drug discovery and clinical development.
Aug 6, 2020
-
Follow the Money: Cash for AI Models, Oncology, Hematology Therapies
Bio-IT World Sema4 gets $121M to build dynamic models of human health and define optimal, individualized health trajectories. Glioblastoma, hematology, and acute pancreatitis all see new funding for therapy development. And AI-powered models net cash.
Aug 5, 2020
-
Ancestry Launches NGS Tests With Family History Component
Bio-IT World | Ancestry has launched AncestryHealth powered by Next Generation Sequencing. It is an upgrade to AncestryDNA + Traits, adding genetic health risk reports, a family health history tool, and other resources.
Aug 4, 2020
-
One Small Step For Open Science, One Giant Leap For Metastasis Research
Bio-IT World | In a first-of-its-kind collaboration, researchers from 19 academically affiliated international laboratories have agreed to share their cell line models specific to brain metastasis with pretty much anyone who asks for them.
Aug 3, 2020
-
New Data on Genetic Expression In Severe COVID-19, Pre-Existing Immune Response
Bio-IT World | Research continues to uncover the underlying biology of SARS-CoV-2 and reveal some surprises. A German team found that 35% of their healthy controls had pre-existing SARS-CoV-2 cross-reactive T cells, and several groups are narrowing down the gene expression signatures that might explain why COVID-19 is so severe in some patients.
Jul 31, 2020
-
Celsius Therapeutics, Twist Bioscience, And More: News From July 2020
Bio-IT World July featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Celsius Therapeutics, Twist Bioscience, and more.
Jul 30, 2020


